Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00443183 · ClinicalTrials.gov registry record · NA

Emergency Physician Brief Interventions for Alcohol

A NA study, sponsored by Yale University.

Completed
Registry status
NA
Development phase
500
Enrollment target

NCT00443183: Completed NA study, sponsored by Yale University.

NCT00443183 is a NA study that has completed, run by Yale University. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00443183, a NA study, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
500 participants
Enrollment target

Study Summary

Patients with hazardous and harmful alcohol consumption are at increased risk for adverse health consequences and have frequent visits to the Emergency Department(ED). Despite research that has demonstrated the prevalence of alcohol problems in ED patients, there are limited data on the effectiveness of brief intervention (BI) strategies for patients in this setting. The purpose of the current study is to evaluate the effectiveness of a brief intervention, termed Brief Negotiation Interview (BNI), provided by emergency practitioners (EPs-emergency physicians and physician assistants), in reducing alcohol consumption in ED patients with hazardous and harmful drinking. In a controlled randomized clinical trial of 500 patients with hazardous and harmful drinking, BNI will be compared to scripted discharge instructions (DI). Three hypotheses will be tested: BNI is superior to DI in: 1) reducing alcohol consumption; 2) reducing the number of binge drinking episodes; and 3) increasing utilization of primary care or alcohol-related services. Alcohol consumption and utilization of primary care or alcohol-related services will be measured by self-report at 1,6 and 12 months. An additional benefit to changing patterns of consumption and utilization of health services may be decreased ED visits and alcohol-related hospitalizations. These will be assessed utilizing a statewide database. In order to facilitate real-world application of BNI in the ED, the project will result in a BNI manual for EPs and an adherence and competence scale. Unique features of the current project as compared to earlier studies include: 1)use of a credible control condition; 2) enrollment of a heterogeneous population; 3)use of a manual-guided intervention by existing ED staff; 4)systematic assessment of adherence and competence to ensure quality administration and discriminability of interventions; 5)monitoring of use of ancillary treatments; and 6)monitoring of repeat ED visits and alcohol-related ho

Interventions

  • BEHAVIORAL Brief Negotiation Interview (BNI)
  • BEHAVIORAL Discharge Instructions

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2002-05
Est. Completion 2004-11
Phase NA
Yale University

1,492 total trials

What the finished NCT00443183 record still lists

NCT00443183 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).

The record links to 0 conditions, and to 2 interventions - of which Brief Negotiation Interview (BNI) is the first listed.

NCT00443183 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00443183 about?

NCT00443183 is a clinical study titled "Emergency Physician Brief Interventions for Alcohol". Patients with hazardous and harmful alcohol consumption are at increased risk for adverse health consequences and have frequent visits to the Emergency Department(ED). Despite research that has demonstrated the prevalence of alcohol problems in ED patients, there are limited data on the effectivenes...

What is the current status of trial NCT00443183?

This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2002-05. Estimated completion is 2004-11.

What interventions are being tested in trial NCT00443183?

The interventions under investigation include: Brief Negotiation Interview (BNI) (BEHAVIORAL), Discharge Instructions (BEHAVIORAL).

Who is sponsoring clinical trial NCT00443183?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00443183's enrollment target sits among peer trials

500 193rd of 2000 higher than 1,788 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00443183, the US trial registry maintained by the National Library of Medicine. NCT00443183 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.